These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7936695)

  • 1. New therapeutic agents marketed in 1993.
    Hussar DA
    Pa Med; 1994 Jul; 97(7):16-8. PubMed ID: 7936695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic agents marketed in 1993.
    Hussar DA
    Pa Med; 1994 Jun; 97(6):22-3. PubMed ID: 8065777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic agents marketed in 1993.
    Hussar DA
    Pa Med; 1994 Apr; 97(4):12-6. PubMed ID: 8008381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic agents marketed in 1993.
    Hussar DA
    Pa Med; 1994 May; 97(5):12-7. PubMed ID: 8036027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic agents marketed in 1995.
    Hussar DA
    Pa Med; 1996 Apr; 99(4):43-6. PubMed ID: 8935886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic agents marketed in 1994.
    Hussar DA
    Pa Med; 1995 May; 98(5):35-8. PubMed ID: 7792092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alomide, a preventive immunopharmaceutical agent, in the treatment of ocular atopy].
    Krásný J
    Cesk Slov Oftalmol; 1998 Jan; 54(1):41-5. PubMed ID: 9501643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical update: new medications for ocular allergy.
    Trayner EM
    N J Med; 1994 Sep; 91(9):607. PubMed ID: 7970285
    [No Abstract]   [Full Text] [Related]  

  • 9. Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999.
    Cross J; Lee H; Westelinck A; Nelson J; Grudzinskas C; Peck C
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):439-46. PubMed ID: 12426927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical look at ocular allergy drugs.
    Joseph Titi M
    Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA approved. New drug bulletin: Cisapride and Dornase alfa.
    RN; 1994 Apr; 57(4):39-42. PubMed ID: 8165421
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF; Khaitova KN; Grishakova MB
    Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent life of antiretroviral drugs approved in the US from 1987 to 2007.
    Rodriguez-Monguio R; Seoane-Vazquez E
    AIDS Care; 2009 Jun; 21(6):760-8. PubMed ID: 19499381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe.
    Kremer B; Tündermann A; Goldschmidt O
    Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009.
    Qureshi ZP; Seoane-Vazquez E; Rodriguez-Monguio R; Stevenson KB; Szeinbach SL
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):772-7. PubMed ID: 21574210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone use in a teaching hospital during its first year after market approval: economic and clinical implications.
    Carter CS; Mulsant BH; Sweet RA; Maxwell RA; Coley K; Ganguli R; Branch R
    Psychopharmacol Bull; 1995; 31(4):719-25. PubMed ID: 8851645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.
    Parrish RW; Davies BH
    Thorax; 1983 Jun; 38(6):458-62. PubMed ID: 6136101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.